Skip to main content

Advertisement

Log in

Brimonidine–timolol fixed combination induced granulomatous inflammation of the eye

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

We report on two cases of granulomatous conjunctivitis and uveitis related with the use of a brimonidine–timolol fixed combination. Case report and a review of medical literature. A 64-year-old man was diagnosed with marked granulomatous uveitis and a 57-year-old woman was diagnosed with granulomatous conjunctivitis. Both patients were using a topical fixed combination of brimonidine 0.2 %-timolol 0.5 % for open angle glaucoma. Bilateral granulomatous uveitis and conjunctivitis were diagnosed after 16 months of treatment with a fixed combination of brimonidine–timolol in both cases. Granulomatous inflammation resolved with the cessation of antiglaucomatous drugs and topical corticosteroid treatment. When the inflammation had resolved completely, both patients were rechallenged with topical brimonidine in one eye only to determine causality. Conjunctival hyperemia is a common side effect of glaucoma medications and is sometimes overlooked. Hyperemia may be associated with other signs such as iritis and keratic precipitates or conjunctival inflammation. In such cases, granulomatous inflammation may be considered in the differential diagnosis. The fixed-combination of brimonidine–timolol may cause this clinical picture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Melamed S, David R (2000) Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Brimonidine Study Group II. Clin Ther 22:103–111

    Article  PubMed  CAS  Google Scholar 

  2. Katz LJ (2002) Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension. J Glaucoma 11:119–126

    Article  PubMed  Google Scholar 

  3. Sherwood MB, Craven ER, Chou C et al (2006) Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial. Arch Ophthalmol 124:1230–1238

    Article  PubMed  CAS  Google Scholar 

  4. Motolko MA (2008) Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy. Curr Med Res Opin 24:2663–2667

    Article  PubMed  CAS  Google Scholar 

  5. Cano PJ, Diaz-Llopis M (2005) Drug induced uveitis. Arch Soc Esp Oftalmol 80:137–149

    Google Scholar 

  6. Becker HI, Walton RC, Diamant JI, Zegans ME (2004) Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate. Arch Ophthalmol 122:1063–1066

    Article  PubMed  Google Scholar 

  7. Byles DB, Frith P, Salmon JF (2000) Anterior uveitis as a side effect of topical brimonidine. Am J Ophthalmol 130:287–291

    Article  PubMed  CAS  Google Scholar 

  8. Alvarado JA (2007) Reduced ocular allergy with fixed-combination 0.2% brimonidine-0.5% timolol. Arch Ophthalmol 125:717–718

    Article  PubMed  Google Scholar 

  9. Acheampong AA, Shackleton M, Tang-Liu DD (1995) Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits. Drug Metab Dispos 23:708–712

    PubMed  CAS  Google Scholar 

  10. Nguyen EV, Azar D, Papalkar D, McCluskey P (2008) Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features. J Glaucoma 17:40–42

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to María Alejandra Carrasco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carrasco, M.A., Schlaen, B.A. & Zárate, J.O. Brimonidine–timolol fixed combination induced granulomatous inflammation of the eye. Int Ophthalmol 33, 557–560 (2013). https://doi.org/10.1007/s10792-012-9688-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9688-0

Keywords

Navigation